Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

4.32
Delayed Data
As of Jun 22
 +0.16 / +3.85%
Today’s Change
2.51
Today|||52-Week Range
7.79
+17.39%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close4.16
Today’s open4.11
Day’s range4.10 - 4.36
Volume541,621
Average volume (3 months)276,115
Market cap$83.2M
Dividend yield--
Data as of 06/22/2017

Growth & Valuation

Earnings growth (last year)+6.31%
Earnings growth (this year)-5.29%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.06

Competitors

 Today’s
change
Today’s
% change
BLRXBioLine RX Ltd+0.00+0.11%
RNNRexahn Pharmaceutica...+0.03+0.97%
ARQLArQule Inc-0.01-0.87%
--Innovative Pharmaceu...0.000.00%
Data as of 06/22/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$0.00
Annual profit (last year)-$19.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Secretary, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts